EDITORIAL SECTION
-
STRATEGY
Strategic Positioning for M&A
The biotechnology sector is characterised by a constant influx of small highly specialised companies
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solutions help reduce contamination risk and lower manual handling
-
CLINICAL TRIALS
Virtual Clinical Trials
Virtual digital and decentralized are all descriptions of the novel ways that using technology changes
-
Bio Pharma
Biosimilars and Biobetters
Biosimilars are biologic medical products that are essentially identical to an original product manufactured
-
MANUFACTURING
Transformative Convergence of AI in Pharmaceutical Manufacturing
The pharmaceutical manufacturing industry is on the cusp of a revolutionary transformation driven by
-
Information Technology
Transformative Impact of Artificial Intelligence on Clinical Trials
Artificial Intelligence AI has rapidly evolved from a futuristic concept to a transformative tool across various industries
-
EXPERT Talk
Pharma's Medical Affairs Bridge: From Field Insights and Stakeholder Needs to Global Scientific Strategy
Medical Affairs has evolved from being primarily a supportive and educational function to becoming a strong strategic partner earlier on Through ongoi...
Advisory Board
.webp "Juris Hmelnickis")
.webp "Eiman Shafa")
KNOWLEDGE BANK
-
Articles
How Single Use Technologies Are Changing Biopharmaceutical Production
For most of the biopharmaceutical industrys history a manufacturing plant was defined by its steel Gleaming tanks fixed piping and miles of welded lines were built to last for decades cleaned and sterilized between every batch and validated at great expense before a single dose left the building That model delivered the first generation of biologics but it was designed for a world of few products...
-
Techno Trends
Lilly’s Jaypirca Gains FDA Approval for First-Line CLL/SLL Treatment
Eli Lilly and Company has received approval from the US Food and Drug Administration FDA for an additional indication for Jaypirca pirtobrutinib in adults with previously untreated chronic lymphocytic leukaemia CLL or small lymphocytic lymphoma SLL without a known p deletion The approval enables Jaypirca to be used as a firstline treatment
-
Projects
Genentech Begins US$750 Million Expansion of Oregon Manufacturing Facility
Genentech a member of the Roche Group has started construction on a US million expansion of its manufacturing facility in Hillsboro Oregon The squarefoot project will double the existing sites footprint and increase US production capacity for advanced drug delivery devices
-
Research Insights
Identification of flavonoids from natural products against hyperlipidaemia through computational approaches
Over the centuries hyperlipidaemia has been recognised as a major risk factor contributing to cardiovascular disease CVD Current research increasingly explores natural compounds such as flavonoids for their potential lipidlowering effects This study evaluated pharmacological potential
-
White Papers
Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact
For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys complexity
TOP ARTICLES
-
1
U.S. Cell and Gene Therapy Market: How Pharma Is Scaling Up
Lakshmi
The U.S. cell and gene therapy market is moving from bespoke, center-by-center breakthroughs toward industrial-scale medicine. This article examines how pharma is scaling up: an advanced-therapy pipel...
-
2
R&D Strategies for First-in-Class and Best-in-Class Therapeutics
Lakshmi
First-in-class and best-in-class therapeutics are not two speeds of the same strategy. They carry different risk profiles, demand different R&D capabilities and now face different pricing clocks u...
-
3
Curcumin’s Role as an Anti-Neurofibrillary Agent Towards Alzheimer's Disease
Sabrina Ruoyao Chen Zhang
Ronny Priefer
Alzheimer’s disease is a progressive neurodegenerative disease that afflicts millions of people globally. Symptoms typically present as memory loss and cognitive decline. Existing hypthoses focu...
-
4
Challenges and Opportunities in Cell and Gene Therapy Manufacturing
Kate Williamson
The widespread use of cell and gene therapy manufacturing gets restricted by three main factors which include high production costs and regulatory complexities along with limited scalability. Modern a...
-
5
The Latest Breakthroughs in Prescription Drug Development
Kate Williamson
New classes of prescription drugs include but are not limited to the following; Personalized medicine; mRNA; gene therapy; Artificial intelligence in drug discovery; Biologics; Long acting formulation...
press releasesRead more...
Kamau Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Nula-cel, a Gene-Corrected Stem Cell Therapy for Sickle Cell Disease
Kamau Therapeutics a clinicalstage company creating medicines that endure by precisely engineering patients own blood stem cells today announced that the US Food and Drug Administration FDA has granted Regenerative Medicine
Resero Analytics Launches TurboLIMS to Accelerate Nonclinical Studies
Resero Analytics today launched TurboLIMS a cloudbased laboratory information management system for GLP and nonGLP studies in toxicology pharmacology pharmacokinetics and toxicokinetics TurboLIMS is a core component of Reseros TurboPlatform
Takara Bio USA Collaborates with the Allen Institute to Enable Spatial Mapping Across Broader Brain Regions with the Trekker® Spatial Biology Platform
Takara Bio USA Inc a wholly owned subsidiary of Takara Bio Inc Takara Bio today announced a significant expansion of its Trekker SingleCell Spatial Mapping Kits with the introduction of largeformat tiles
Argenx to Acquire Unnatural Products, Inc., Adding Peptide Discovery Engine to Broaden Immunology Capabilities
Argenx the immunology innovation company today announced a definitive agreement to acquire Unnatural Products Inc UNP adding a macrocyclic peptide discovery engine to its immunology innovation capabilities argenx which already holds a minority stake in UNP will acquire all remaining shares in a tran...
Events Read more...
11 - 13
Nov 2026Frontiers in Cancer Science 2026
One Farrer Hotel,1 Farrer Park...
16 - 17
Nov 2026Analytics for Smarter Decisions in Pharma
London, UK
24 - 27
Nov 2026Pharmtech & Ingredients 2026
Crocus Expo, Pavilion 2, Mosco...
24 - 25
Nov 2026BioPharma Deals Conference 2026
Science Congress Center, Munic...
26 - 28
Nov 2026One Health Conference 2026
Thapar Institute of Engineerin...
01 - 03
Dec 2026Pharmaceutical Launch Excellence Summit
Novotel Amsterdam City, Nether...
01 - 03
Dec 202610th Antifibrotic Drug Development
Boston, MA at the Hotel Common...
02 - 04
Dec 2026Genome Informatics 2026
Wellcome Genome Campus, UK
LATEST NEWSRead more...
Cyclarity Therapeutics Receives FDA Clearance for UDP-003 Clinical Trial Application in the US
Cyclarity Therapeutics Inc has received clearance from the US Food and Drug Administration FDA for its Investigational New Drug IND application for UDP enabling the company to expand its atherosclerosis clinical development programme into the United States
Santhera Signs Distribution Agreement with SteinCares for AGAMREE in 31 Latin American and Caribbean Countries
Cyclarity Therapeutics Inc has received clearance from the US Food and Drug Administration FDA for its Investigational New Drug IND application for UDP enabling the company to expand its atherosclerosis clinical development programme into the United States
Oncolytics Biotech Signs Clinical Supply Agreement to Evaluate Pelareorep with LOQTORZI in Anal Cancer
Oncolytics Biotech Inc Nasdaq ONCY a clinicalstage immunotherapy company developing pelareorep has signed a clinical supply agreement with Coherus Oncology to evaluate pelareorep in combination with LOQTORZI toripalimabtpzi in patients with squamous cell anal carcinoma SCAC
MD Logic Health and Blu Vitals Launch Nine-Form Magnesium Supplement Mag 9+
MD Logic Health has partnered with Blu Vitals to launch Mag the first product developed through their collaboration The new magnesium supplement combines nine forms of magnesium with four additional nutrients in a daily formula designed to support energy production muscle and nerve function and bon...
PharmAla Biotech Signs Supply and Data Agreement with Aalborg University Hospital for Danish Randomized Trial of MDMA-Assisted Treatment for Service-Related PTSD
PharmAla Biotech Holdings Inc a biotechnology company focused on the research development and manufacturing of MDXXclass molecules including its proprietary LaNeo MDMA announces that it has signed a Project Supply Agreement the Agreement with the North Denmark Region
PharmAla Signs Agreement and Initiates R&D with Corealis Pharma for GMP Manufacturing of its patented ALA-002 Drug Product
PharmAla Biotech Holdings Inc a biotechnology company focused on the research development and manufacturing of MDXXclass molecules including its proprietary LaNeo MDMA announces that it has signed an agreement with Corealis Pharma Inc Corealis a GMPcompliant contract development
